The Achilles' heel of HIV treatment for prevention: History of sexually transmitted coinfections among people living with HIV/AIDS receiving antiretroviral therapies

Journal of the International Association of Physicians in AIDS Care

Volumn 10, Issue 6, 2011, Pages 365-372

  Kalichman, Seth C ^a   Cherry, Chauncey ^a   White, Denise ^a   Jones, Mich'L ^a   Kalichman, Moira ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

HIV prevention; STI; test and treat

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; CHLAMYDIA; CLINICAL ASSESSMENT; CLINICAL EXAMINATION; CONTROLLED STUDY; FEMALE; GENITAL HERPES; GONORRHEA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MIXED INFECTION; PRIORITY JOURNAL; REVIEW; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; SUBSTANCE ABUSE; SYPHILIS; TRANSSEXUALISM; TRICHOMONIASIS; ACQUIRED IMMUNE DEFICIENCY SYNDROME;

ACQUIRED IMMUNODEFICIENCY SYNDROME; COINFECTION; HIV INFECTIONS; HUMANS; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASES;

EID: 83455162714     PISSN: 15451097     EISSN: 15570886     Source Type: Journal    
DOI: 10.1177/1545109711418120     Document Type: Review

References (33)

1. Advancing HIV Prevention: New Strategies for a Changing Epidemic-United States. Morb Mortal Wkly Rep. 2003 ; 52 (15). 329-332
2. Dieffenbach C, Fauci A. Universal voluntary testing and treatment for prevention of HIV transmission. JAMA. 2009 ; 301 (22). 2380-2382
3. Wilson DP, Law MG, Grulich AE, Cooper DA, Kaldor JM. Relation between HIV viral load and infectiousness: a model-based analysis. Lancet. 2008 ; 372 (9635). 314-320 (Pubitemid 352020440)
4. Granich RM, Gilks CF, Dye C, De Cock KM, Williams BG. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet. 2009 ; 373 (9657). 48-57
5. Blower SM, Gershengorn HB, Grant RM. A tale of two futures: HIV and antiretroviral therapy in San Francisco. Science. 2000 ; 287 (5453). 650-654 (Pubitemid 30070912)
6. De Cock KM, Crowley SP, Lo YR, Granich RM, Williams BG. Preventing HIV transmission with antiretrovirals. Bull World Health Organ. 2009 ; 87 (7). 488 - A
7. De Cock KM, Gilks CF, Lo YR, Guerma T. Can antiretroviral therapy eliminate HIV transmission?. Lancet. 2009 ; 373 (9657). 7-9
8. Cohen MS, Gay CL. Treatment to prevent transmission of HIV-1. Clin Infect Dis. 2010 ; 50 (suppl 3). S85 - S95
9. Vernazza P, Hirschel B, Bernasconi E, Flepp M. HIV-positive individuals without additional sexually transmitted diseases (STD) and on effective anti-retroviral therapy are sexually non-infectious. Bulletin Des Médecins Suisses. 2008 ; 89 (5). 165-169
10. Cohen MS. HIV Treatment as Prevention and "The Swiss Statement": in for a Dime, in for a Dollar?. Clin Infect Dis. 2010 ; 51 (11). 1323-1324
11. Hasse B, Ledergerber B, Hirschel B, et al. Frequency and determinants of unprotected sex among HIV-infected persons: The Swiss HIV Cohort Study. Clin Infect Dis. 2010 ; 51 (11). 1314-1322
12. Kalichman SC. Co-occurrence of treatment nonadherence and continued HIV transmission risk behaviors: implications for positive prevention interventions. Psychosom Med. 2008 ; 70 (5). 593-597
13. Murillo W, Paz-Bailey G, Morales S, et al. Transmitted drug resistance and type of infection in newly diagnosed HIV-1 individuals in Honduras. J Clin Virol. 2010 ; 49 (4). 239-244
14. Hamers RL, Siwale M, Wallis CL, et al. HIV-1 drug resistance mutations are present in six percent of persons initiating antiretroviral therapy in Lusaka, Zambia. J Acquir Immun Defic Syndr. 2010 ; 55 (1). 95-101
15. Cohen MS, Hoffman IF, Royce RA, et al. Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1. Lancet. 1997 ; 349 (9069). 1868-1873 (Pubitemid 27270120)
16. Coleman JS, Hitti J. Bukusi EA, et al Infectious correlates of HIV-1 shedding in the female upper and lower genital tracts. AIDS. 2007 ; 21 (6). 755-759 (Pubitemid 46568633)
17. Kalichman SC, Cage M, Barnett T, et al. Human immunodeficiency virus in semen and plasma: investigation of sexual transmission risk behavioral correlates. AIDS Res Hum Retroviruses. 2001 ; 17 (18). 1695-1703 (Pubitemid 34114207)
18. Kalichman SC, Pellowski J, Turner C. Prevalence of sexually transmitted co-infections in people living with HIV/AIDS: systematic review with implications for using HIV treatments for prevention. Sex Transm Infect. 2011 ; 87 (3). 183-190
19. Mayer KH, O'Cleirigh C, Skeer M, et al. Which HIV-infected men who have sex with men in care are engaging in risky sex and acquiring sexually transmitted infections: findings from a Boston community health centre. Sex Transm Infect. 2010 ; 86 (1). 66-70
20. Gribble JN, Miller HG, Cooley PC, Catania JA, Pollack L, Turner CF. The impact of T-ACASI interviewing on reported drug use among men who have sex with men. Subst Use Misuse. 2000 ; 35 (6-8). 869-890
21. Morrison-Beedy D, Carey MP, Tu X. Accuracy of audio computer-assisted self-interviewing (ACASI) and self-administered questionnaires for the assessment of sexual behavior. AIDS Behav. 2006 ; 10 (5). 541-552 (Pubitemid 44285075)
22. Kalichman SC, Rompa D, Cage M. Reliability and validity of self-reported CD4 lymphocyte count and viral load test results in people living with HIV/AIDS. Int J STD AIDS. 2000 ; 11 (9). 579-585
23. Bangsberg DR, Hecht FM, Charlebois ED, Chesney M, Moss A. Comparing objective measures of adherence to HIV antiretroviral therapy: electronic medication monitors and unannounced pill counts. AIDS Behav. 2001 ; 5 (3). 275-281 (Pubitemid 35364540)
24. Kalichman SC, Amaral CM, Swetzes C, et al. A simple single-item rating scale to measure medication adherence: further evidence for convergent validity. J Int Assoc Physicians AIDS Care (Chic). 2009 ; 8 (6). 367-374
25. Jaworski BC, Carey MP. Development and psychometric evaluation of a self-administered questionnaire to measure knowledge of sexually transmitted diseases. AIDS Behav. 2007 ; 11 (4). 557-574 (Pubitemid 46828772)
26. Napper L, Fisher DG, Reynolds GL, Johnson ME. HIV risk behavior self-report reliability at different recall periods. AIDS Behav. 2010 ; 14 (1). 152-181
27. Cohen MS, Kashuba AD. Antiretroviral therapy for prevention of HIV infection: new clues from an animal model. PLoS Med. 2008 ; 5 (2). e30
28. Kashuba AD, Dyer JR, Kramer LM, Raasch RH, Eron JJ, Cohen MS. Antiretroviral-drug concentrations in semen: implications for sexual transmission of human immunodeficiency virus type 1. Antimicrob Agents Chemother. 1999 ; 43 (8). 1817-1826 (Pubitemid 29395171)
29. Kalichman SC. Co-occurrence of treatment non-adherence and continued HIV transmission risk behaviors: implications for positive prevention interventions. Psychosom Med. 2008 ; 70 (5). 593-597
30. Schroder K, Carey MP, Vanable P. Methodological challenges in research on sexual risk behavior: i item content, scaling, and data analytic options. Ann Behav Med. 2003 ; 26 (2). 76-103 (Pubitemid 37271596)
31. Simoni J, Kurth AE, Pearson C, Pantalone DW, Merrill J, Frick P. Self-report measures of antiretroviral therapy adherence: a review with recommendations for HIV research and clinical management. AIDS Behav. 2006 ; 10 (3). 227-245
32. Cohen MS, Mastro TD, Cates W. Universal voluntary HIV testing and immediate antiretroviral therapy. Lancet. 2009 ; 373 (9669). 1077
33. Kalichman SC, DiBerto G, Eaton L. HIV viral load in blood plasma and semen: review and implications of empirical findings. Sex Transm Dis. 2008 ; 35 (1). 55-60 (Pubitemid 351619353)